POSITRON CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.1 USD | 0.00% |
|
-4.35% | -29.94% |
| 2023 | Positron Corporation Announces New Customer Utilizing Positron?S Attrius PET System and Services | CI |
| 2023 | Positron Corporation Announces Attrius®? Pet System Sale | CI |
| Sales 2013 | 1.63M 130M | Sales 2014 | 1.47M 117M | Capitalization | 7.26M 579M |
|---|---|---|---|---|---|
| Net income 2013 | -7M -558M | Net income 2014 | -2M -160M | EV / Sales 2013 | 6.92 x |
| Net Debt 2013 | 4.31M 344M | Net Debt 2014 | 862K 68.77M | EV / Sales 2014 | 5.54 x |
| P/E ratio 2013 |
-0.98
x | P/E ratio 2014 |
-1.86
x | Employees | 19 |
| Yield 2013 * |
-
| Yield 2014 |
-
| Free-Float | 95.99% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 week | -4.35% | ||
| Current month | -10.57% | ||
| 1 month | +6.80% | ||
| 3 months | -22.10% | ||
| 6 months | -12.00% | ||
| Current year | -29.94% |
1 week
1.10
1.30
1 month
1.031.30
Current year
1.001.60
1 year
0.871.97
3 years
0.072.25
5 years
0.002.25
10 years
0.003.60
| Managers | Title | Age | Since |
|---|---|---|---|
Adel Abdullah
PSD | President | 51 | - |
Karen Barry
ADM | Chief Administrative Officer | - | - |
| Sales & Marketing | - | 23/06/22 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Adel Abdullah
PSD | President | 51 | - |
Tis Prager
BRD | Director/Board Member | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/05/24 | 1.1 | 0.00% | 350 |
| 30/04/24 | 1.1 | 0.00% | 7,843 |
| 29/04/24 | 1.1 | -4.35% | 2,257 |
| 26/04/24 | 1.15 | -8.00% | 779 |
| 24/04/24 | 1.25 | +8.70% | 3,141 |
Delayed Quote OTC Markets, May 01, 2024 at 07:34 pm
More quotes
Positron Corporation is a molecular imaging device company, which offers a positron emission tomography (PET) imaging system and clinical services to nuclear medicine healthcare providers throughout North America. The Company is specialized in the field of cardiac PET imaging, the gold standard in cardiac diagnostics. Its PET technology, clinical services and imaging practice solutions enables healthcare providers to diagnose coronary artery disease and improve patient outcomes through providing medicine. It offers nuclear cardiologists its Attrius PET nuclear imaging device, technical and clinical services, and can provide financing solutions to meet the needs of hospitals and medical imaging practices. Its products and services enables healthcare providers to diagnose CAD and improve patient outcomes.
| 1st Jan change | Capi. | |
|---|---|---|
| -29.94% | 28.52M | |
| -3.25% | 15.01B | |
| -38.91% | 2.8B | |
| -12.68% | 2.45B | |
| -12.18% | 1.46B | |
| -.--% | 1.12B | |
| +43.80% | 518M | |
| +92.56% | 505M | |
| +14.23% | 245M | |
| -19.37% | 183M |
- Stock Market
- Equities
- POSC Stock
